BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Korenbaum C, Pierard L, Thiéry A, Story F, Lindner V, Lang H, Kurtz J, Barthélémy P. Treatments, Outcomes, and Validity of Prognostic Scores in Patients With Sarcomatoid Renal Cell Carcinoma: A 20-Year Single-Institution Experience. Clinical Genitourinary Cancer 2018;16:e577-86. [DOI: 10.1016/j.clgc.2017.12.005] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Mikhail M, Chua KJ, Khizir L, Tabakin A, Singer EA. Role of metastasectomy in the management of renal cell carcinoma. Front Surg 2022;9. [DOI: 10.3389/fsurg.2022.943604] [Reference Citation Analysis]
2 Teishima J, Murata D, Inoue S, Hayashi T, Mita K, Hasegawa Y, Kato M, Kajiwara M, Shigeta M, Maruyama S, Moriyama H, Fujiwara S, Matsubara A. Prediction of early progression of metastatic renal cell carcinoma treated with first-line tyrosine kinase inhibitor. Curr Urol 2021;15:187-92. [PMID: 35069080 DOI: 10.1097/CU9.0000000000000042] [Reference Citation Analysis]
3 Huang J, Wang Y, Zhang H, Hu X, Wang P, Cai W, Yuan Y, Zeng H, Zhang J, Kong W, Huang Y, Wang S, Guo J, Wei Q, Xue W. Clinical outcomes of second-line treatment following first-line VEGFR-TKI failure in patients with metastatic renal cell carcinoma: a comparison of axitinib alone and axitinib plus anti-PD-1 antibody. Cancer Commun (Lond) 2021. [PMID: 34363742 DOI: 10.1002/cac2.12206] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
4 Blum KA, Gupta S, Tickoo SK, Chan TA, Russo P, Motzer RJ, Karam JA, Hakimi AA. Sarcomatoid renal cell carcinoma: biology, natural history and management. Nat Rev Urol 2020;17:659-78. [PMID: 33051619 DOI: 10.1038/s41585-020-00382-9] [Cited by in Crossref: 33] [Cited by in F6Publishing: 35] [Article Influence: 11.0] [Reference Citation Analysis]
5 Gan CL, Dudani S, Heng DYC. Prognostic and Predictive Factors in Metastatic Renal Cell Carcinoma: Current Perspective and a Look Into the Future. Cancer J 2020;26:365-75. [PMID: 32947304 DOI: 10.1097/PPO.0000000000000468] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
6 Yang B, Xia H, Xu C, Lu M, Zhang S, Wang G, Ma L. Impact of sarcomatoid differentiation and rhabdoid differentiation on prognosis for renal cell carcinoma with vena caval tumour thrombus treated surgically. BMC Urol 2020;20:14. [PMID: 32070319 DOI: 10.1186/s12894-020-0584-z] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]
7 Buonerba C, Dolce P, Iaccarino S, Scafuri L, Verde A, Costabile F, Pagliuca M, Morra R, Riccio V, Ribera D, De Placido P, Romeo V, Crocetto F, Longo N, Imbimbo C, De Placido S, Di Lorenzo G. Outcomes Associated with First-Line anti-PD-1/ PD-L1 agents vs. Sunitinib in Patients with Sarcomatoid Renal Cell Carcinoma: A Systematic Review and Meta-Analysis. Cancers (Basel) 2020;12:E408. [PMID: 32050629 DOI: 10.3390/cancers12020408] [Cited by in Crossref: 24] [Cited by in F6Publishing: 24] [Article Influence: 8.0] [Reference Citation Analysis]
8 Marszalek M. First-line treatment of metastatic renal cell carcinoma: current standard of care. memo 2019;12:334-338. [DOI: 10.1007/s12254-019-00550-7] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
9 Silagy AW, Mano R, Blum KA, DiNatale RG, Marcon J, Tickoo SK, Reznik E, Coleman JA, Russo P, Hakimi AA. The Role of Cytoreductive Nephrectomy for Sarcomatoid Renal Cell Carcinoma: A 29-Year Institutional Experience. Urology 2020;136:169-75. [PMID: 31726184 DOI: 10.1016/j.urology.2019.08.058] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
10 Bian L, Duan J, Wang X, Yang Y, Zhang X, Xiao S. Sarcomatoid Chromophobe Renal Cell Carcinoma: A Case Report and Review of the Literature. Am J Case Rep 2019;20:1225-30. [PMID: 31423007 DOI: 10.12659/AJCR.916651] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
11 Huang Z, Du Y, Zhang X, Liu H, Liu S, Xu T. Clear cell renal cell carcinoma bone metastasis: What should be considered in prognostic evaluation. Eur J Surg Oncol 2019;45:1246-52. [PMID: 30760414 DOI: 10.1016/j.ejso.2019.01.221] [Cited by in Crossref: 10] [Cited by in F6Publishing: 13] [Article Influence: 2.5] [Reference Citation Analysis]
12 Wang Z, Zeng X, Chen R, Chen Z. Ki-67 index and percentage of sarcomatoid differentiation were two independent prognostic predictors in sarcomatoid renal cell carcinoma. Cancer Manag Res 2018;10:5339-47. [PMID: 30464630 DOI: 10.2147/CMAR.S176242] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]